These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3304737

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An immunohistological study of human hepatic graft-versus-host disease.
    Dilly SA, Sloane JP.
    Clin Exp Immunol; 1985 Dec; 62(3):545-53. PubMed ID: 3910317
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory cells in graft-versus-host disease on the rectum: immunopathologic analysis.
    Weisdorf SA, Roy J, Snover D, Platt JL, Weisdorf DJ.
    Bone Marrow Transplant; 1991 Apr; 7(4):297-301. PubMed ID: 2070136
    [Abstract] [Full Text] [Related]

  • 4. The cellular composition of human lymph nodes after allogenic bone marrow transplantation: an immunohistological study.
    Dilly SA, Sloane JP, Psalti IS.
    J Pathol; 1986 Nov; 150(3):213-21. PubMed ID: 3543275
    [Abstract] [Full Text] [Related]

  • 5. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
    Atkinson K.
    Bone Marrow Transplant; 1986 Dec; 1(2):121-32. PubMed ID: 2971408
    [Abstract] [Full Text] [Related]

  • 6. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 7. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

  • 10. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J, Casaño J, Alvarez MA, Roman-Gomez J, Martin C, Martinez F, Gomez P, Serrano J, Herrera C, Torres A.
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [Abstract] [Full Text] [Related]

  • 11. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY, Kwok J, Lie AK, Chen P, Chen FE, Liang R.
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [Abstract] [Full Text] [Related]

  • 12. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F, Raffoux C, Griscelli C, Fischer A.
    J Immunol; 1987 Jan 15; 138(2):423-7. PubMed ID: 3540121
    [Abstract] [Full Text] [Related]

  • 13. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB.
    Bone Marrow Transplant; 1994 Nov 15; 14(5):725-35. PubMed ID: 7889005
    [Abstract] [Full Text] [Related]

  • 14. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 15; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 15. T-lymphocyte subsets in the lesional skin of allogeneic and autologous bone marrow transplant patients.
    Paller AS, Nelson A, Steffen L, Gottschalk L, Kaizer H.
    Arch Dermatol; 1988 Dec 15; 124(12):1795-801. PubMed ID: 3056281
    [Abstract] [Full Text] [Related]

  • 16. T-lymphocyte subpopulations identified by monoclonal antibodies after human bone-marrow transplantation.
    Tubiana N, Maraninchi D, Mawas C, Lecaer F, Sainty D, Sebahoun G, Olive D, Gastaut JA, Carcassonne Y.
    Pathol Biol (Paris); 1985 Mar 15; 33(3):173-8. PubMed ID: 3892443
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.